Fintech PR
Stefanini Group acquired Solve.it, an Italian company providing IT services, to accelerate its growth in Italy and Europe
- Stefanini Italy will have a team of over 300 people following the transaction
- Solve.it focuses on large customers from all major industries
- The founders will remain on the company’s board of directors to ensure the seamless integration of Solve.it into the Stefanini ecosystem.
TURIN, Italy, Sept. 12, 2023 /PRNewswire/ — Stefanini Group, a global tech multinational with a presence in 41 countries that assists customers in their digital transformation, acquired Solve.it, an Italian company that provides IT consulting, application development, and management services. This acquisition will enhance Stefanini’s market position and accelerate its growth in Italy and Europe.
Solve.it was founded in 2003 in Turin by Giuseppe Arietti and provides IT and Operations Management services, with focus on large customers across all technological fields. Over the years, Solve.it acquired Arxis, a company focused on SAP technology services, and other small companies that have allowed it to enhance its capabilities with new skills and specializations.
The company is specialized in Information technology infrastructure, end users and application services. Key reference platforms and technologies include SAP, ServiceNow, Cornerstone, IBM Maximo, Microsoft and Oracle.
The company operates in automotive, engineering, financial services, public sector, industrial & automation, food & beverage, manufacturing, defense, transport, large home appliances, and pharmaceuticals.
Solve.it has more than 200 employees, all located in Italy (in Turin headquarters, as well as in Milan and Bologna offices). Following this acquisition, Stefanini Italy team will reach over 300 people.
Another important aspect of Stefanini’s decision is related to the customer portfolio. Solve.it’s portfolio includes over 30 customers in the past years, five major global players in the automotive industry, one of the top banks, and a significant coffee industry, underscoring the importance of global Italian brands in this strategic expansion, as well as two important pharmaceutical companies.
The transaction was made by Stefanini Group and the company will be integrated to Stefanini Europe, the Middle East and Africa (EMEA) operations, headquartered in Brussels.
Solve.it will go through a smooth transition to integrate the full team with Stefanini Italy and Stefanini EMEA. The founders and management will remain in the company to help Stefanini Italy ensure a seamless integration for the employees and customers.
The opportunity to strengthen Stefanini’s portfolio in Italy with more “local power.”
“Our commitment is to continually offer new services, tailored to the needs of our customers. Besides developing these services internally, by investing in research and development, we are always looking at what other similar or complementary companies are creating. Solve.it is our first acquisition in Italy and we are confident that this transaction will significantly enhance our growth efforts in Italy, Europe and EMEA”, said Marco Stefanini, Global CEO and Founder of Stefanini Group.
“This acquisition is a strategic move to enhance and reinforce our offering in Italy, to enhance Stefanini’s position in Europe, and to accelerate its growth in the market.
This move reflects Stefanini’s commitment to staying at the forefront of technology solutions and further establishing itself as a leading player in the region Solve.it offers similar solutions as Stefanini and is therefore a good addition to strengthen our portfolio, especially in Italy with a more «local approach.” At the same time, our model is to give autonomy to the founders and the actual management in order to keep the cultural aspects of this successful Italian company. The relationship between Solve.it within the Italian market and CIOs is very important, so yes, we will grow, but we are going to stay Italian”, said Farlei Kothe, CEO of Stefanini EMEA.
Customer loyalty was also a key factor in Stefanini’s decision to close this deal: Solve.it has almost 100% contract renewal with very high customer satisfaction. This is crucial for Stefanini, as the company attaches a lot of importance to customer satisfaction, as shown by the excellent results with a NPS score of 63 last year.
This is Stefanini’s first acquisition in Italy. The discussion started in April 2023.
“It was an obvious strong match and A good agreement that made both parties align easily. Our strong focus on modern technology solutions, blue-chip clients from all technological fields, and especially the excellent relationship we have with these clients convinced Stefanini Group management to invest in Italy and in this partnership with Solve.it“, stated Giuseppe Arietti, CEO and Founder of Solve.it.
About Stefanini Group
Stefanini is a global tech multinational, originating from Brazil, with 35 years of experience on the market and a presence in 41 countries. The company invests in a complete innovation ecosystem to serve main industry verticals and assist customers in their digital transformation. With robust offers aligned with market trends such as automation, cloud, Internet of Things (IoT) and User Experience (UX), the company has received recognitions as well as several awards in the innovation area. Currently, the Brazilian multinational has a broad portfolio, which combines innovative consulting and marketing solutions, mobility, personalized campaigns and artificial intelligence with traditional solutions such as Service Desk (with the ability to offer support in 35 languages), Field Service and outsourcing (BPO).
About Solve.it
Solve.it supports IT Service and Operations Management and the digital transformation of its customers through an end-to-end service design approach by providing consulting, application development and management services. Solve.it was founded in Turin in 2003 and has offices in Milan and Bologna. The group is focused on large customers and is present in all technological fields, including the most innovative ones. It operates in the Automotive, Industrial, Food and Rail, Aerospace and Naval sectors.
Photo – https://mma.prnewswire.com/media/2207158/Solveit.jpg
Photo- https://mma.prnewswire.com/media/2207159/Stefanini_Group.jpg
Logo – https://mma.prnewswire.com/media/2053451/Stefanini_Group_Logo.jpg
Logo – https://mma.prnewswire.com/media/2208268/Solveit_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/stefanini-group-acquired-solveit-an-italian-company-providing-it-services-to-accelerate-its-growth-in-italy-and-europe-301924809.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
https://news.cision.com/eqt/i/eqt-ab-group,c3285895 |
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News4 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News5 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News4 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News5 days ago
COP28 President calls on all stakeholders to bring spirit of solidarity that delivered UAE Consensus to drive implementation and sustainable socio-economic development
-
Latest News3 days ago
TWSE Becomes the First Exchange to Receive ISO 14068-1 Carbon Neutrality Certificate